BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ: BNTX)

Overview
current price
$102.14
$102.14
change
0.00 | 0.00%
0.00 | 0.00%
Yesterday's Close
102.14
open
0.00
volume
0.00 M
30d. avg volume.
0.90 M
1 day
0.00 - 0.00
52 weeks
76.53 - 131.49
p/e
0.00
beta
0.2413
market cap
24.29 B
dividend yield
0.00%
Industry
-
News and Commentary
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows Moderna Inc. (MRNA&nbs...
UK, Taiwan Approve Moderna's Updated COVID-19 Shot On Tuesday, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Moderna, Inc.'s
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program Starting in late September, U.S. households can order up to four COVID-19 nasal swab tests when the federal program reopens.The exact date for ordering...
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to...
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study On Friday, Pfizer Inc. (PFE
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D S... Monday, BioNTech SE (BNTX
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5... Wednesday, GSK plc (GSK...
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents Pfizer Inc. (PFE 
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment AstraZeneca PLC (AZN&nb...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season On Friday, Moderna Inc. (MRNA...
StockTwits
StockTwits

Join now and unlock premium features